The use of medicines in children is an area of increasing after this syndrome was noted, pharmacokinetic studies showed that newborn infants had impaired metabolism interest [ 1] . Many medicines are being used outside the terms of their product licence [2 ] thereby increasing of chloramphenicol and that a reduction of the dosage from 100 mg kg−1 daily to 50 mg kg−1 daily prevented the risk of drug toxicity. Clinicians need to ensure not only that toxicity is kept to a minimum but also that the development of this syndrome [12 ] . children are not denied the use of appropriate medicines. This can only be achieved by the scientific study of drug toxicity in children and is ideally carried out by prospective studies of drug surveillance. This involves Toxicity in young children specifically monitoring for drug toxicity, either in relation to particular drugs [3, 4] or selected patient Although these initial studies described clinical problems groups [5, 6] . Drug use in children may be accompanied in newborn infants, and the preterm infant in particular, by problems not seen in adults, or cause adverse drug problems with other drugs have highlighted the reactions that are more frequent than in adults. An enhanced toxicity of some medicines in children. example of this is metoclopramide which causes dystonia Hepatotoxicity in association with the anticonvulsant in teenagers and Parkinsonism in the elderly [7 ] .
sodium valproate was initially reported in 1979 [ 13] . Subsequently more than 100 patients died, the majority of whom were children. A retrospective review [ 14] of 37 patients who died in the USA, showed that those patients at greatest risk fell into one of three categories: Antibiotic toxicity in neonates (i) age under 3 years; (ii) receiving other anticonvulsants as well as valproate; (iii) developmental delay. Infections have always been a major problem in neonates with significant mortality and morbidity. The introducSubsequent changes in prescribing habits resulted in a dramatic reduction in the number of deaths due to tion of antibiotic therapy resulted in major clinical advances [ 8] . However, antibiotic therapy also prosodium valproate [15] . The mechanism of valproate hepatotoxicity is not fully understood but is thought to duced particular clinical problems. Silverman et al. reported considerably higher mortality in neonates relate to abnormal metabolism [ 16] . Other anticonvulsants result in enzyme induction and, therefore, enhance receiving a combination of penicillin and sulphisoxazole than those receiving oxytetracycline [9 ] . There was a certain metabolic pathways resulting in the formation of toxic intermediate metabolites. These pathways may significantly higher incidence of kernicterus, both clinically (opisthotonos, spasticity, seizures, oculogyric movebe more prominent in children under the age of 3 years and it is important to realise that drug metabolism in ments) and pathologically (yellow staining of the brain) in the children who died following penicillin and the children differs from that of adults. The other drug causing hepatotoxicity specifically in sulphonamide. Subsequently, others have shown that sulphonamides are highly protein bound and displace children was aspirin. The use of salicylates in children with a mild viral infection resulted in a greater risk of bilirubin from albumin [ 10] . As the preterm infant is usually jaundiced, the sulphonamide displaced bilirubin developing Reye's syndrome-a life threatening illness associated with drowsiness, coma, hypoglycaemia, seizfrom albumin and this is thought to increase the incidence of kernicterus.
ures and liver failure. admitted to hospital with Reye's syndrome and their ill olites. Children, however, have an enhanced capacity for sulphation and therefore less paracetamol undergoes classmates as control subjects, during an outbreak of influenza A. The seven children with Reye's syndrome oxidation and less hepatotoxic oxidative metabolites are formed. The liver has the capacity for detoxifying these all took salicylates in comparison with eight of the 16 control subjects. The patients took larger doses of oxidative metabolites utilising glutathione. Children are thought to have greater hepatic stores of glutathione salicylates than the control group and the level of salicylate consumption correlated with the severity of which also helps to minimise hepatotoxicity [ 28] . the Reye's syndrome. The subsequent warning that salicylate should not be used for children in general, led to a dramatic reduction in the incidence of Reye's syndrome. The mechanism of the toxicity remains Renal excretion and toxicity unknown and salicylates, in the absence of viral infection, do not predispose to the development of Reye's
The other major elimination pathway involves renal excretion. This is impaired in fullterm neonates in the syndrome or hepatotoxicity.
first few days of life [29 ] . It is also impaired in preterm infants in the first few weeks of life and, therefore, drugs that are excreted renally, such as aminoglycosides, are administered less frequently during the neonatal period.
Drug metabolism and toxicity
In infants and children outside the neonatal period, renal function is normal and does not predispose The toxicity of sulphonamides and chloramphenicol in the neonate, and sodium valproate and salicylates in children to enhanced toxicity. young children have emphasised the need to study the relationship between drug metabolism and age in more detail. The major pathways for drug metabolism include oxidation by hepatic cytochrome P450 enzymes and Formulation also conjugation to glucuronides and sulphates [19 ] .
The activity of many of the P450 enzymes is reduced It is important to realise that medications given to children contain not only the desired drug but also in the neonatal period [20 ] . The rate by which enzyme activity subsequently increases varies considerably. This other compounds which are added to make the drug more soluble, palatable etc. The most tragic example of is illustrated by the drug caffeine which has markedly diminished clearance in preterm neonates and adult an adverse reaction to ingredients is the use of diethylene glycol as a solvent for sulphanilamide which resulted in clearance values by the age of 6 months [21 ] . The metabolism of caffeine is complex and whereas the death of at least 76 Americans in 1937 [ 30] . Subsequently, diethylene glycol has been used as a 8-hydroxylation activity reaches adult levels by the age of 1 month, N3 and N7 demethylation do not reach solvent for paracetamol resulting in the death of 47 children in Nigeria [31 ] and 51 in Bangladesh [32 ] . adult levels until the age of 4 months [22 ] . Midazolam undergoes oxidation predominantly by CYP3A4. The
It is a credit to colleagues in these two countries that further deaths were avoided by the awareness of clinical clearance of midazolam is impaired in infants and children under the age of 3 years, in comparison with suspicion of ADRs due to a constituent rather than the primary component of the medicine administered. children aged 3 years and older [ 23] . The variation in maturation of different enzymes makes it difficult to predict dosage requirements accurately at different ages. This results in an increased susceptibility to toxicity.
Glucuronidation is a major process of drug eliminDrug surveillance in children and neonates ation in adults, but is significantly reduced in neonates. Paracetamol and morphine are both drugs where Although some cases of drug toxicity such as chloramphenicol were recognised rapidly and dosage modified, glucuronidation is the major metabolic pathway. In the case of paracetamol there is compensatory sulphation the toxicity of other drugs such as aspirin and sodium valproate were not recognised for many years. In order so the half-life is similar in children of all ages [24 ] . This is in contrast to morphine where sulphation is a to anticipate drug related toxicity in children, drug surveillance schemes were carried out in paediatric minor pathway in all ages including neonates [25 ] . The glucuronidation of morphine is reduced in the neonatal in-patients. These initial studies were carried out in North American hospitals [ 33, 34] and subsequently period but because there is no enhanced sulphation the half-life in neonates is considerably longer [ 26] . similar studies were carried out in British hospitals [35, 36] . Hepatotoxicity is common following an overdose of paracetamol in adults and adolescents. In children, Adverse drug reactions (ADRs) occurred in between 5.6 and 16.8% paediatric inpatients in these studies however, severe hepatotoxicity is uncommon and only seven deaths in children have been reported world wide [33] [34] [35] [36] [37] . It is difficult, however, to extrapolate this data which is based on studies in highly specialised children's [ 27] . Following an overdose in adults, the normal metabolic pathways (glucuronidation and sulphation) hospitals to smaller paediatric units or the community. The incidence of ADRs is heavily biased by the inclusion are saturated. Paracetamol then undergoes oxidation with the production of hepatotoxic oxidative metabof certain types of patients who are more likely to
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'off-label' and unlicensed drugs in paediatric intensive care
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identify which types of drugs are more likely to cause reported by nurses and pharmacists with only a 
